Skip to Content

M 274 (Tamoxifen Citrate 20 mg)

Pill with imprint M 274 is White, Round and has been identified as Tamoxifen Citrate 20 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer, metastatic; breast cancer; breast cancer, male; breast cancer, palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 274

Tamoxifen citrate 20 mg M 274
Tamoxifen citrate 20 mg M 274 Front
Tamoxifen citrate 20 mg M 274 Back
Tamoxifen citrate 20 mg M 274

Tamoxifen Citrate

Imprint
M 274
Strength
20 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Hormones/antineoplastics, Selective estrogen receptor modulators
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-0274
Inactive Ingredients
lactose anhydrous, silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M 274"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.